Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA

INTRODUCTION: Effective glycemic control can reduce the risk of complications and their related costs in type 2 diabetes mellitus (T2DM). However, many patients fail to reach glycemic targets, often because of adverse effects of treatment (including hypoglycemia or weight gain). The present analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunt, Barnaby, Mocarski, Michelle, Valentine, William J., Langer, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435780/
https://www.ncbi.nlm.nih.gov/pubmed/28281218
http://dx.doi.org/10.1007/s12325-017-0502-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435780/
https://www.ncbi.nlm.nih.gov/pubmed/28281218
http://dx.doi.org/10.1007/s12325-017-0502-2

Ejemplares similares